HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$31.38
Day range
$30.73 - $31.58
Year range
$25.28 - $46.48
Market cap
4.88B USD
Avg Volume
2.03M
P/E ratio
11.07
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 161.71M | 92.79% |
Operating expense | 104.25M | 67.87% |
Net income | 390.90M | 9,974.61% |
Net profit margin | 241.73 | 5,120.95% |
Earnings per share | 0.16 | 704.50% |
EBITDA | 29.38M | 136.09% |
Effective tax rate | -1,408.72% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.58M | -61.42% |
Total assets | 1.03B | 74.91% |
Total liabilities | 417.81M | 6.08% |
Total equity | 607.22M | — |
Shares outstanding | 146.20M | — |
Price to book | 7.37 | — |
Return on assets | 8.50% | — |
Return on capital | 10.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 390.90M | 9,974.61% |
Cash from operations | -23.15M | -89.70% |
Cash from investing | 46.36M | 596.71% |
Cash from financing | -78.24M | -158.19% |
Net change in cash | -55.03M | -148.74% |
Free cash flow | -39.04M | -25.94% |
About
Founded
1993
Headquarters
Website
Employees
374
